WO1999021511A1 - Appareil et procede d'augmentation mammaire - Google Patents

Appareil et procede d'augmentation mammaire Download PDF

Info

Publication number
WO1999021511A1
WO1999021511A1 PCT/US1997/019733 US9719733W WO9921511A1 WO 1999021511 A1 WO1999021511 A1 WO 1999021511A1 US 9719733 W US9719733 W US 9719733W WO 9921511 A1 WO9921511 A1 WO 9921511A1
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
procedure
breast
enhancement
nipple
Prior art date
Application number
PCT/US1997/019733
Other languages
English (en)
Inventor
John D. Jeter
James J. Fournet
Original Assignee
Jeter John D
Fournet James J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jeter John D, Fournet James J filed Critical Jeter John D
Priority to PCT/US1997/019733 priority Critical patent/WO1999021511A1/fr
Priority to AU51571/98A priority patent/AU5157198A/en
Publication of WO1999021511A1 publication Critical patent/WO1999021511A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses and implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/42—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for desensitising skin, for protruding skin to facilitate piercing, or for locating point where body is to be pierced
    • A61M5/425—Protruding skin to facilitate piercing, e.g. vacuum cylinders, vein immobilising means

Definitions

  • This invention pertains to human breast enhancement and more particularly to enlargement of the breast by the placement of enhancement fluids within the natural fluid reservoir, or containment definable as the gland lobule and related lactatous ducts, by injection of fluid into the apertures of the nipple.
  • breast configuration enhancement is being provided by surgically implanting a sac of fluid between the existing breast and the rib cage to push the visible portion of the breast outward.
  • the implant can only be removed surgically.
  • the presence of an implanted body of foreign material is now a cause for concern and a better method is needed to satisfy the utility defined by an expensive and controversial practice now existing.
  • the breast is capable of producing milk, storing the milk and delivering it to the nipples upon demand.
  • This capability has provided a reservoir, related ducts, and a non intrusive entry port needed for artificial enhancement by inserting tissue compatible fluid in the opposite direction. Fluid compatible with the host tissue is essential but the insertion is practical.
  • the novel procedure for breast enhancement involves normal clinical practice in cleaning the nipples before fluid insertion.
  • no tissue is broken and insertion, rather than injection, is the appropriate term.
  • the second choice involves the use of a blunt needle that cuts no tissue but does enter the nipple opening to extend some distance along the associated duct.
  • the third option involves the use of a catheter that extends from a manual control into the nipple opening and along the lactiferous duct to at least the ampulla and flowing the inserted liquid along the catheter.
  • the fourth option involves needle penetration of the dermal cover and into the ampulla and injecting enhancement fluid.
  • the nipple sometimes tends to shrink and fold the lactiferous duct such that it is reluctant to receive a blunt needle or catheter.
  • the duct apparatus is provided to apply a moderate vacuum to the nipple.
  • the preferred apparatus comprises, in effect two watch glasses with an elastomer ring between the two providing some separating space.
  • One watch glass has a hole to receive the nipple and bear against the breast.
  • the second watch glass has a plurality of holes to receive catheters or blunt needles.
  • the elastomer ring has a duct for the introduction of a moderate vacuum between the watch glasses.
  • the holes in the outer watch glass can be plugged or covered by a thin tab of rubber sheet until ready for the insertion of a catheter.
  • each hole can be opened by removal of a plug or tab and a catheter is inserted through that hole and into the aligned duct while the moderate vacuum is sustained.
  • Enhancement fluids can be fed independently to each catheter or all catheters can be fed from a common reservoir. Reservoir pressure can be safely sustained by elevating the reservoir or by applying moderate and limited air pressure to a suitable reservoir to propel the fluid into the catheters.
  • Fluid can be delivered into the breast without contacting the surface of the breast by impinging a jet of enhancement fluid against the opening of the lactiferous duct at the nipple.
  • the jet represents fluid pressure converted to velocity and the velocity is converted back to pressure when the jet is stopped by impingement. If the point of impingement is the duct opening the pressure exists in the duct and does not bear upon the surrounding area.
  • the duct is dilated and fluid is accepted if the duct is receptive. This procedure is devoid of preferred volume and installation pressure controls but does provide access to some problem lactiferous ducts.
  • fat deposits may provide tortuous paths for the ducts related to each gland lobule and insertion of fluid new to the overall breast structure may produce unusual breast conformation. This can be somewhat corrected, especially during fluid insertion, by the application of vibration that apparently causes relative movement between tissue masses and allows fluid to pass in areas that would normally be restricted or blocked.
  • some air or other gas may be used.
  • the gas is best applied by first emulsifying it with the liquid to be inserted. Finely emulsified, the gas is slow to aggregate into larger bubbles and to separate from the liquid. Once the two phase fluid is installed in the small interstices of the breast it tends to stay in place and cannot be readily distinguished by sensory processes. This is especially true when autogenous fat and compressible fluids are emulsified.
  • the volumetric percentage of gas needed to satisfactorily reduce the specific gravity of the installation is small and even doubling the gas volume due to ambient pressure change, even large altitude changes, indicate no resulting problems.
  • figure l illustrates the usual breast structure.
  • Figure 2 is a side view, with a sagittal view of the breast, and illustrates the simplest form of the enhancement fluid insertion apparatus.
  • Figure 3 is a side view, with a sagittal view of the breast, and illustrates an alternate apparatus using catheters to insert enhancement fluid into the breast.
  • Figure 4 is a side view, with a sagittal view of the breast, and illustrates the use of a penetrating needle to inject enhancement fluid onto the breast.
  • Figure 5 is a sagittal view of a breast with the anatomical features abbreviated showing a common problem found when using the lactatous duct for fluid insertion.
  • Figure 6 is a side view of a nipple erecting appliance prepared for use in aiding the installation of enhancement fluid insertion apparatus.
  • Figure 7 is a view similar to that of figure 6 with fluid insertion apparatus in place.
  • Figure 8 is a sagittal view, anatomically abbreviated, of the breast with lactatous ducts occluded by apparatus of this invention.
  • Figures 9, 10, and 11 are side views of three preferred forms of occluding apparatus shown in figure 8.
  • Figure 12 is a side view of a ring vibrator preferred for use in facilitating distribution of enhancement fluid within the breast.
  • Figure 13 is a side view, somewhat enlarged and mostly in cut away, of a single catheter with a surrounding tube to aid in catheter acceptance into the duct.
  • Figure 14 is a side view, mostly in cut away, of an emulsifier accessory for conditioning the enhancement fluid.
  • Figure 15 is a side view, mostly cut away and rather enlarged, of a valve for the lactiferous duct.
  • Figure 16 is identical to figure 15 except for an installation and service tool in the usual use situation.
  • Figure 17 is a side view, mostly cut away, of an alternate form of the apparatus for fluid installation.
  • Figure 18 is a view from the right side of figure 17.
  • FIG 1 a sagittal view of the breast is shown in the usual, but abbreviated, anatomical format.
  • lactatous systems There are usually several independent lactatous systems present but only two are shown to illustrate primary features that affect the design of apparatus of this invention.
  • the breast 1 has the nipple 2 with apertures openable to the lactiferous ducts 3 which have enlargements 4, called ampulla, connected with the connective ducts 5 extending to the gland lobules 6.
  • Each connected set of features 3, 4, 5, and 6 comprise one of the average breasts several independent lactatous systems as defined herein.
  • a simple form of enhancement fluid insertion apparatus includes nozzle 7 supplied fluid by tube 8, controlled by clamp 9, with enhancement fluid from reservoir 11 in container 12. Fluid flows from the nozzle into an aperture of the nipple 2 common to duct 3, through ampulla 4, along connective duct 5 into the gland lobule 6 to enlarge breast 1.
  • FIG 3 the usual breast 1 and nipple 2 are shown with two lactatous systems to illustrate use of two catheters 13a and 13b to insert enhancement fluids.
  • the first catheter 13a extends through the lactiferous duct 3 and opens into the ampulla 4. This exposes the ampulla to the inflowing pressure and, in some cases can cause unsightly enlargement of the breast near the nipple.
  • Catheter 13b is inserted to extend well into the connective duct 5. This prevents exposure of the ampulla to the inflowing pressure.
  • Both catheters, in any one case, will probably be used alike but are as shown for descriptive convenience.
  • the catheters are shown to be fed fluid from a common feed septum 14 served by a common reservoir 11 in container 12 by way of tube 8, controlled by clamp 9. Pressure available to the catheters is limited to the fluid head E to prevent excess pressure consequence.
  • Figure 4 shows the usual sagittal section, anatomically abbreviated, with a piercing needle 15 inserted through the dermal cover of the breast to and into the ampulla.
  • Syringe 16 is shown for inclusion of possible reservoirs.
  • the other reservoirs disclosed herein can be used to feed fluid to the needle 15. This use of a piercing needle is an optional procedure that is of secondary interest but it is anticipated by and is within the scope of the claims.
  • Figure 5 illustrates a problem that may be encountered in traversing the lactiferous duct with blunt needles or catheters.
  • the nipple 2 tends to shrink in length and contributes to the fluid retention ability of the lactiferous duct by folding or creasing the duct. That impedes entry into the duct when the penetrating device encounters a fold.
  • FIGS. 6 and 7 illustrate means to straighten the lactiferous ducts that experience the problem shown in figure 5.
  • a watch glass 17 or similar member has a hole in it to accept the nipple and bears upon the breast.
  • An elastomer ring 19 serves as a spacer between watch glass 17 and watch glass 18 such that watch glass 18 remains somewhat above the nipple when it is distended.
  • a moderate vacuum is applied to the ring between the watch glasses and causes the nipple to distend, straightening the lactiferous ducts.
  • Watch glass 18 has a plurality of holes illustrated by 18a to accept the catheter or blunt needle and they are individually covered by a thin rubber sheet tab 23. Rubber plugs can be used instead of tabs if preferred.
  • Ring 19 may be adhered to watch glass 17 but watch glass 18, somewhat lubricated, rests atop the ring and it can be moved laterally to align selected holes 18a with apertures in the nipple. Each tab is removed when the related hole is properly positioned and a blunt needle or catheter is inserted and moved into the lactiferous duct.
  • a catheter 13 is shown in figure 6. When the catheters are all inserted they can all be collectively inserted into holes in the collector septum 14 shown in figure 3. Tube 8 serves the function previously described herein. As shown in figure 7 the catheters or blunt needles, blunt needle 13 shown, can be fed by individual supply tubes 8 which can be individually supplied with fluid from flexible bags S shown in the background.
  • Figure 8 shows the use of plugs 24, preferably formed from gold dental wire, with a final oval shape inserted into the lactiferous duct.
  • the plugs resist movement along the duct but can be removed by applying finger pressure at the back of the nipple. This plug prevents enhancement fluid from flowing out of the breast until the breast adapts to the change in shape and pressure.
  • Figures 9, 10, and 11 show three preferred types of plugs each insertable with a thin walled tube with an outside diameter about the same as the diameter of the plug.
  • the tube is immediately removed.
  • Shape A moves with little force in either direction within the duct.
  • Shape B with convolutions Bl holds position more firmly.
  • Shape C more sharply tapered Cl on the left end and a more abrupt taper C2 on the right end moves to the right when subjected to lateral squeezing of the duct it serves.
  • Figure 12 shows a hand held vibrator 25 fitted with a ring 26 that oscillates the globules within the breast while enhancement fluid is being installed.
  • the breast internal structure is probably never geometrically distributed in perfect order but time, activity, and the pendulous weight causes such relative position changes that the connective ducts may be pinched against fluid flow.
  • the lactating breast seems to work these problems out in time but the rather short term changes related to enhancement offers no such time.
  • the vibrator enhances the flow distribution by temporarily and frequently changing any flow interference.
  • the ring can surround the watch glasses, if used, and does not impede their function.
  • Figure 13 shows apparatus and procedure for easier insertion of a catheter 13 into a nipple aperture.
  • the catheter is first pushed against the aperture surface.
  • a stream of water, not destined for installation in the breast, is then projected from tube 30 against the aperture.
  • the aperture tends to open and accept the catheter. This flow is wasted by streams 32.
  • the tube 30 is slipped off the catheter after the catheter is in place.
  • Figure 14 shows a blender type high speed emulsifier, driven by motor 36, for the mixing of air, or other suitable gas, admitted by tube 38 into the enhancement fluid 39 in the reservoir 35.
  • the air serves two purposes. It reduces the specific gravity of the enhancement fluid and it is compressible to retain a reasonable pressure within the enhanced breast to reduce the tendency for the enhanced breast to promptly sag.
  • Impeller 36a spinning at high speed induces air to be drawn through tube 38 into the fluid. When finely emulsified, the air is slow to aggregate into larger bubbles and the fluid changes little in the time needed for insertion into the breast by way of tube 35a. Compressible fluid is especially stable in autogenous fat when finely emulsified. Lid 37 prevents splash and supports tube 38.
  • Figures 15 and 16 show a check valve, normally about one millimeter in diameter, for use in the lactiferous duct, to provide simplicity in long term care.
  • Body 40 has a channel extending axially and comprising threaded opening 40a, valve seat 40b, and opening 40d.
  • Spring 41 urges ball 42 against seat 40b to prevent flow of fluid to the right which will be toward the nipple outlet of the duct.
  • Hollow tool 43 has a tapered thread 43b to mate with threads 40c. When the tool is threaded into the body 40 a protuberance on the tool 43c lifts ball 42 off the seat and fluid can flow in either direction through the valve and tool which is tubular. Notch 43a prevents the ball from sealing the bore of the tool.
  • Efforts are now being made to devise the valve entirely of compatible plastic with the movable element, equivalent to ball 42, molded as part of the body. This will not change the essence of the functional description and the configuration will be much as shown.
  • FIGS 17 and 18 show apparatus for injecting fluid into troublesome lactatous ducts by velocity induced internal pressure.
  • a jet J of enhancement fluid is projected from tube 52 to impinge against a duct opening (not shown) at the nipple surface. In an impinging jet the velocity head is converted back to pressure which is internal to the duct and the impinged fluid will flow along the now opened channel.
  • Another form of nipple lifting suction appliance is shown with no surface bearing upon breast 1.
  • Nipple 2 is drawn into the opening 50a by mild suction admitted along bore 50c of the handle 50.
  • Cover 51 has spherical surface 4lb resting on mating surface 50b with hole 51a to accept tube 52.
  • Spring clip 53 holds cover 51 in place in the absence of suction in opening 50a.
  • air or other gas
  • as an enhancement fluid is part of this disclosure, especially as a short term aid for the breast to accommodate change before the fluid is changed out to liquid. That is anticipated by and is within the scope of the claims.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

On augmente la taille des seins par élargissement, en introduisant des fluides compatibles avec le corps humain dans les poches à lait naturelles des seins et en faisant passer le liquide constitué par ces fluides par les ouvertures des canaux galactophores au niveau des mamelons. On crée l'écoulement, depuis une source de fluide sous pression, en dirigeant un jet de liquide dans l'ouverture des canaux galactophores, en pressant le conduit de fluide contre cette ouverture ou en pénétrant cette ouverture avec un cathéter à aiguille mousse ou équivalent. Pour faciliter la pénétration de cette ouverture, on propose un appareil d'aspiration qui détend le mamelon pour raidir les canaux galactophores. Des obturateurs sont proposés pour améliorer la capacité de rétention du fluide. L'obturateur peut être plein ou à valve, de façon à ne permettre l'écoulement du fluide qu'au moment de l'introduction d'un instrument de manipulation de l'obturateur. Un appareil d'émulsification des fluides est proposé pour conditionner les fluides, lesquels peuvent contenir un liquide aqueux salin, un fluide compressible et des substances autogènes, seuls ou associés les uns aux autres.
PCT/US1997/019733 1997-10-29 1997-10-29 Appareil et procede d'augmentation mammaire WO1999021511A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US1997/019733 WO1999021511A1 (fr) 1997-10-29 1997-10-29 Appareil et procede d'augmentation mammaire
AU51571/98A AU5157198A (en) 1997-10-29 1997-10-29 Breast enhancement apparatus and procedure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/019733 WO1999021511A1 (fr) 1997-10-29 1997-10-29 Appareil et procede d'augmentation mammaire

Publications (1)

Publication Number Publication Date
WO1999021511A1 true WO1999021511A1 (fr) 1999-05-06

Family

ID=22261970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/019733 WO1999021511A1 (fr) 1997-10-29 1997-10-29 Appareil et procede d'augmentation mammaire

Country Status (2)

Country Link
AU (1) AU5157198A (fr)
WO (1) WO1999021511A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945496A (en) * 1958-08-18 1960-07-19 Fosdal Alfred Dental instrument for immobilizing tissue
DE3019589A1 (de) * 1974-11-19 1981-01-15 Wolfgang Dr.Med. 1000 Berlin Wagner Sauginjektion mit gespeichertem unterdruck im einstichbereich
US5423760A (en) * 1991-12-06 1995-06-13 Yoon; Inbae Automatic retractable safety penetrating instrument
WO1996011647A1 (fr) * 1994-10-17 1996-04-25 Seare William J Jr Procedes et appareil permettant de creer une poche corporelle
EP0725141A1 (fr) * 1993-10-18 1996-08-07 Tovarischestvo S Organichennoi Otvetstvennostju "Bioprogress" Procede de transformation genetique maitrise de la glande mammaire d'un animal et dispositif d'introduction de matiere genetique dans les canaux galactophores de la glande mammaire d'un animal
US5683420A (en) * 1995-12-11 1997-11-04 John D. Jeter Breast enhancement apparatus and procedure

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945496A (en) * 1958-08-18 1960-07-19 Fosdal Alfred Dental instrument for immobilizing tissue
DE3019589A1 (de) * 1974-11-19 1981-01-15 Wolfgang Dr.Med. 1000 Berlin Wagner Sauginjektion mit gespeichertem unterdruck im einstichbereich
US5423760A (en) * 1991-12-06 1995-06-13 Yoon; Inbae Automatic retractable safety penetrating instrument
EP0725141A1 (fr) * 1993-10-18 1996-08-07 Tovarischestvo S Organichennoi Otvetstvennostju "Bioprogress" Procede de transformation genetique maitrise de la glande mammaire d'un animal et dispositif d'introduction de matiere genetique dans les canaux galactophores de la glande mammaire d'un animal
WO1996011647A1 (fr) * 1994-10-17 1996-04-25 Seare William J Jr Procedes et appareil permettant de creer une poche corporelle
US5683420A (en) * 1995-12-11 1997-11-04 John D. Jeter Breast enhancement apparatus and procedure

Also Published As

Publication number Publication date
AU5157198A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
US5800534A (en) Breast enhancement apparatus and method
US4421505A (en) Wound irrigation system
EP0391511B1 (fr) Canule d'aspiration chirurgicale, en particulier pour liposuccion
AU651710B2 (en) Bidirectional valved catheter
US3664339A (en) Drip chamber and method
US6283940B1 (en) Catheter
US4750643A (en) Sterile fluid dispensing system and method
CA2119243C (fr) Dispositif et methodes de lavage medical
US4029095A (en) Device for circulating treating fluid through the nasal fossae
US5071104A (en) Three-way elastic valve for a wound irrigation apparatus
JPH0663588B2 (ja) 弁を備えた接続装置
GB2085732A (en) Administration set
US4926856A (en) Feeding system
JP3529311B2 (ja) 眼内手術装置
US6695821B1 (en) Surgical infusion tool with flow diffuser
US5904715A (en) Breast enhancement apparatus and procedure
AU8554698A (en) Catheter valve
DE2919343A1 (de) Tropfkammer fuer infusionsgeraete
US4553956A (en) Shunt valve and method of use
US6113568A (en) Vein catheter for coaxial blood stream and use of a split needle for its introduction in a vein
GB2040687A (en) Catheter delivery system
WO1999021511A1 (fr) Appareil et procede d'augmentation mammaire
MXPA00004196A (es) Aparato para agrandar el pecho y procedimiento
US4713054A (en) Implanted muscle powered drug dispensing system
US4413987A (en) Wound irrigation system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/004196

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA